Explore more Articles in

BioTech

Gold Prices Under Pressure as Tariff Talks Offset Geopolitical Risks

Tariff Negotiations Weigh Down on Gold Gold () rose slightly on Friday as markets adjusted amid evolving trade headlines. However, it pulled back during the...

Oil Price Retreats but Bullish Technicals Suggest Upside Ahead

The NA session kicks off quietly, with subdued volumes as American traders take the day off, giving markets a breather after the upside surprise...

Stocks Week Ahead: Can Small-Business Optimism, Inflation Clues Keep Bulls Alive?

There’s not much on this week’s economic calendar. The only big event was supposed to occur on Wednesday, July 9. That would have been...

June Payrolls Jump, but Other Growth Indicators Paint a Sluggish Picture

June beats consensus on the back of education and health services employment, while private NFP surprises downside. With S&P Global monthly flat...
BioTech

Regeneron’s Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myeloma – Regeneron Pharmaceuticals (NASDAQ:REGN)

The U.S. Food and Drug Administration (FDA) granted accelerated approval to Regeneron Pharmaceuticals, Inc.’s REGN Lynozyfic (linvoseltamab-gcpt) for adult patients with relapsed or refractory...
BioTech

How Zevra’s Miplyffa Could Transform Investment Strategies – Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics, Inc. ZVRA is turning a quiet FDA approval into a broader comeback story. HC Wainwright initiated coverage on the rare disease drugmaker...
BioTech

Merck’s Hypertension Drug On FDA Fast Track For Label Expansion – Merck & Co (NYSE:MRK)

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review for Merck & Co. Inc.’s MRK new supplemental Biologics License Application...
BioTech

Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons – Pfizer (NYSE:PFE)

The House Judiciary Committee has subpoenaed Dr. Philip Dormitzer, a former Pfizer Inc. PFE executive, in connection with an investigation into claims that the...
BioTech

Why Is Oscar Health Stock Falling Wednesday – Oscar Health (NYSE:OSCR)

Oscar Health, Inc. OSCR stock is trading lower on Wednesday, in reaction to Centene Corp.’s CNC decision to withdraw its 2025 earnings guidance.This move...
BioTech

Trump-Administration’s Health Agency Overstepped Authority, Reorganization Unlawful: Court

In a sharp blow to the Trump administration’s downsizing agenda, U.S. District Judge Melissa DuBose issued a preliminary injunction halting the March 27, 2025...
123...18Page 2 of 18

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.